LEGN Legend Biotech Corp

USD 56.93 1.03 1.842576
Icon

Legend Biotech Corp (LEGN) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 56.93

+1.03 (+1.84)%

USD 11.84B

0.63M

USD 80.46(+41.34%)

USD 0.00 (-100.00%)

Icon

LEGN

Legend Biotech Corp (USD)
COMMON STOCK | NSD
USD 56.93
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 11.84B

USD 0.00 (-100.00%)

USD 56.93

Legend Biotech Corp (LEGN) Stock Forecast

Show ratings and price targets of :
USD 80.46
(+41.34%)

Based on the Legend Biotech Corp stock forecast from 7 analysts, the average analyst target price for Legend Biotech Corp is USD 80.46 over the next 12 months. Legend Biotech Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Legend Biotech Corp is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Legend Biotech Corp’s stock price was USD 56.93. Legend Biotech Corp’s stock price has changed by -5.16% over the past week, -18.66% over the past month and +21.21% over the last year.

No recent analyst target price found for Legend Biotech Corp
No recent average analyst rating found for Legend Biotech Corp

Company Overview Legend Biotech Corp

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationall...Read More

2101 Cottontail Lane, Somerset, NJ, United States, 08873

0

December

USD

USA

Adjusted Closing Price for Legend Biotech Corp (LEGN)

Loading...

Unadjusted Closing Price for Legend Biotech Corp (LEGN)

Loading...

Share Trading Volume for Legend Biotech Corp Shares

Loading...

Compare Performance of Legend Biotech Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for LEGN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Legend Biotech Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing LEGN

Symbol Name LEGN's Weight Expense Ratio Price(Change) Market Cap
MEDI
Harbor Health Care ETF 4.59 % 0.80 % +0.18 (+0.68%) USD6.79M

Frequently Asked Questions About Legend Biotech Corp (LEGN) Stock

Based on ratings from 7 analysts Legend Biotech Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 6 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on LEGN's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for LEGN is USD 80.46 over the next 12 months. The maximum analyst target price is USD 93 while the minimum anlayst target price is USD 65.

Unfortunately we do not have enough data on LEGN's stock to indicate if its overvalued.

The last closing price of LEGN's stock was USD 56.93.

The most recent market capitalization for LEGN is USD 11.84B.

Based on targets from 7 analysts, the average taret price for LEGN is projected at USD 80.46 over the next 12 months. This means that LEGN's stock price may go up by +41.34% over the next 12 months.

Following are ETFs with the highest allocation to Legend Biotech Corp's stock :

MEDI

As per our most recent records Legend Biotech Corp has 0 Employees.

Legend Biotech Corp's registered address is 2101 Cottontail Lane, Somerset, NJ, United States, 08873. You can get more information about it from Legend Biotech Corp's website at https://www.legendbiotech.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...